The vanilloid receptor 1 (VR1) is a ligand-gated, nonselective cation channel important for the sensory processing of painful stimuli. Activation of VR1 leads to increases in intracellular concentrations of calcium and sodium. Prolonged activation of VR1 in mammalian expression systems leads to cell death. The mechanism of VR1-mediated toxicity may have relevance to pathophysiological processes that can occur in neurons. Therefore, we have evaluated the relative contributions of intracellular calcium and sodium changes to VR1-mediated toxicity in human embryonic kidney 293 cells stably transfected with the human VR1 channel. The data demonstrate that VR1 receptor agonists capsaicin and resiniferatoxin lead to a sustained increase in intracellular calcium and sodium in a concentration-dependent manner, followed by cell death. Pretreatment with VR1 receptor antagonists capsazepine or ruthenium red block both the calcium and sodium responses to agonists, and block agonist-induced cell death in a concentration-dependent manner. However, addition of antagonists several minutes after agonists selectively reverses the agonist-induced increase in intracellular calcium, but does not reverse the elevated intracellular sodium concentration. Nonetheless, antagonists retain protective efficacy against capsaicin toxicity when added several minutes after capsaicin, conditions in which the cells still manifest elevated intracellular sodium, but not elevated intracellular calcium. In addition, a transient VR1-mediated increase in intracellular calcium that returns to baseline within minutes, induced by a rapid drop in pH, from pH 7.5 to pH 6.3, also does not lead to cell death. Collectively, these data demonstrate that the most important intracellular ionic change for mediating VR1-dependent toxicity is a sustained increase of calcium.
The VR1 receptor is a ligand-gated, nonspecific cation channel activated by vanilloid compounds, low pH, and noxious heat (Tominaga et al., 1998) . The best-known natural vanilloids are capsaicin, which is the pungent ingredient in hot chili peppers, and resiniferatoxin, synthesized by a cactus-like plant called Euphorbia resinifera . High temperatures, Ͼ42°C, protons, and high concentrations of anandamide gate the VR1 receptor directly (Tominaga et al., 1998 , and an efflux of K ϩ . A number of ionic mechanisms have been implicated in cell death, including Ca 2ϩ (Choi, 1987; Munir et al., 1995; Grant et al., 1997) , Na ϩ (Raymond et al., 1996; Itoh et al., 1998) , and K ϩ (Yu et al., 1999) . In the dorsal root ganglion, capsaicin treatment results in selective degeneration of approximately 50% of the sensory neurons of neonatal rats, and approximately 18% of these neurons in adult rats (Holzer, 1991; Jancso, 1992) . When capsaicin is administered to adult rats peripherally, it results in marked peripheral nerve fiber degeneration in organs such as skin, ureter, and duodenum (Hoyes and Barber, 1981; Chung et al., 1985 Chung et al., , 1990 . Nociceptor terminals are destroyed reliably, but complete death of the cell bodies does not always occur. In both adult and newborn rats, the capsaicin-induced neurodegeneration is restricted to the subpopulation of small C-type primary sensory neurons (Jancso et al., 1977 (Jancso et al., , 1985 , which are the predominant VR1-expressing neurons (Caterina et al., 1997) . Evidence suggests that capsaicin-induced damage of C-fiber neurons may lead to transganglionic degeneration (Mannion et al., 1996) . Toxic capsaicin treatment also results in increased calcium influx over a sustained period of time, consistent with a role for intracellular calcium in the mechanism of capsaicin-induced sensory neuron degeneration (Jancso et al., 1978 (Jancso et al., , 1984 .
Both the rat and human VR1 receptors have been cloned (Caterina et al., 1997; Dubin et al., 2000; Hayes et al., 2000) . hVR1 consists of 839 amino acids with six putative transmembrane domains (Dubin et al., 2000; Hayes et al., 2000) , 92% homology to rat VR1, and a single nucleotide polymorphism resulting in a valine to isoleucine substitution at residue 585 located in transmembrane domain 5 (Hayes et al., 2000) . When expressed in Xenopus oocytes or HEK293 cells, the hVR1 receptor exhibits pharmacological and physiological properties similar to those observed for the native vanilloid receptor, originally identified and characterized in sensory neurons (Dubin et al., 2000; Hayes et al., 2000) . Much research in heterologous expression systems to date has focused on the pharmacology of VR1-mediated currents and intracellular calcium responses (Caterina et al., 1997; Tominaga et al., 1998; Dubin et al., 2000; Hayes et al., 2000) . However, very little research has focused on characterization of VR1-mediated intracellular sodium responses, or the downstream cellular signaling consequences of VR1-mediated ion flux.
VR1 appears to mediate capsaicin-induced pain responses in vivo because this effect is eliminated in VR1 knockout mice (Caterina et al., 2000) . Prolonged capsaicin exposure to VR1-transfected non-neuronal cells induces intracellular calcium responses and cell death (Caterina et al., 1997) . Therefore, VR1 is a good candidate molecule for explaining the mechanism by which a distinct subpopulation of sensory neurons dies in response to capsaicin in vivo. Because the VR1 channel is permeable to both sodium and calcium, and mediates the influx of both of these ions into the cell, it is important to determine the relative calcium and sodium ion contributions to VR1-mediated cell death. The role these ions play in cell death is important for understanding the mechanism by which VR1 activation can kill cells and may begin to explain the mechanistic basis for capsaicin-induced neurodegeneration in vivo. Therefore, we have evaluated the ionic dependence of VR1-mediated cell death in VR1-expressing HEK293 cells. These data suggest that sustained, increased intracellular calcium, but not sodium concentration, primarily mediates VR1-dependent toxicity in these cells.
Experimental Procedures
Materials. Capsaicin, resiniferatoxin, capsazepine, ruthenium red, and propidium iodide (PI) were all purchased from Sigma Chemical (St. Louis, MO). Fura-2/AM, SBFI/AM, fluo-4/AM, and CM-H 2 DCFDA were all purchased from Molecular Probes (Eugene, OR).
Cloning and Transfection of hVR1 into HEK293 Cells. The hVR1 cDNA was isolated by screening of a human thalamus library and cloned as previously described (Dubin et al., 2000) . HEK293 cells were transfected with hVR1 in pcDNA3.1zeo(ϩ) by using the Effectene nonliposomal lipid-based transfection kit (QIAGEN, Valencia, CA). hVR1/HEK293 cells were routinely grown as monolayers under selection (zeocin; 200 g/ml; Invitrogen, Carlsbad, CA) in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum, glutamine (2 mM), and penicillin/streptomycin (50 units/ml) in 5% CO 2 at 37°C. Cells were passaged frequently, every 3 to 5 days, to avoid acidic medium exposure. Cells were passaged without enzymes or Ca 2ϩ chelators. Stably expressing hVR1 cell lines were screened for expression by using fluo-3/AM in conjunction with a FLIPR (FL-101; Molecular Devices, Sunnyvale, CA) at room temperature. The clones exhibiting the most robust influx of Ca 2ϩ upon application of capsaicin were studied further but clone 3 was used for all subsequent studies because the response to capsaicin was robust for Ͼ30 passages (hVR1/HEK). Zeocin-resistant clones were shown to express the intact exogenous human VR1 receptor gene by using reverse transcription-polymerase chain reaction of primers designed to produce a product corresponding to coding and vector 3Ј-untranslated sequences (data not shown).
Ca 2؉ Influx Measurements with FLIPR. Transfected cells were seeded onto poly-D-lysine-coated, black-walled 96-well plates (Biocoat, 354640; BD Biosciences, San Jose, CA) at about 40,000 cells/well and grown for at least 1 day in culture medium to confluence. On the day of the experiment, media were removed using a 12-prong aspirator, incubated in 100 l of fluo-3 (2 M; Molecular Probes) with pluronic acid (0.04%; Molecular Probes) for 1 h at room temperature. After loading the cells, the fluo-3 was aspirated, 160 l of buffer was added to all wells, and intracellular Ca 2ϩ levels were subsequently assayed using the FLIPR (Molecular Devices) to simultaneously monitor fluo-3 fluorescence in all wells ( excitation ϭ 488 nm, emission ϭ 540 nm). Cells were challenged with agonists (at 10-fold concentration in 20 l added to 180 l at a velocity of 20 l/s) and the fluorescence intensity was captured every 3 s for the first 3 min after agonist addition. The contents of the wells were mixed three times (40 l) after the additions. Antagonists were added on line (9-fold concentration in 20 l added to 160 l at a velocity of 20 l/s) and fluorescence intensity was captured every 3 s for 3 min before agonist addition. The saline buffer used for these experiments contained 130 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 20 mM HEPES, pH 7.4).
[ 3 H]Resiniferatoxin Binding Assay. Cell membranes were prepared by washing cells with Hanks' balanced salt solution (HBSS). Cells were dissociated with cell dissociation buffer (Sigma Chemical) and then centrifuged at 1000g for 5 min. Cell pellets were homogenized in cold 20 mM HEPES buffer, pH 7.4, containing 5.8 mM NaCl, 320 mM sucrose, 2 mM MgCl 2 , 0.75 mM CaCl 2 , and 5 mM KCl and centrifuged at 1000g for 15 min. The resultant supernatant was then centrifuged at 4000g for 15 min. The pellet membranes were stored at Ϫ80°C. The binding assay procedure was modified from what has been described previously (Szallasi and Blumberg, 1993) . Briefly, about 120 g of protein/ml membranes was incubated with the indicated concentration of [ 3 H]RTX (PerkinElmer Life Sciences, Boston, MA) in 0.5 ml of the HEPES buffer, pH 7.4, containing 0.25 mg/ml fatty acid-free bovine serum albumin at 37°C for 60 min and the reaction mixture was cooled to 4°C. Then ␣ 1 -acid glycoprotein (0.1 mg) was added to each sample and was incubated at 4°C for 15 min. The samples were centrifuged at 18,500g for 15 min. The tip of the microcentrifuge tube containing the pellets was cut off. The nonspecific binding was tested in the presence of 200 nM unlabeled RTX. Bound radioactivity was quantified by scintillation counting.
Cytoxicity Measurements. Cell viability was measured using two methods. The first method is a single-cell digital imaging-based method. Visible light digital images of the cells were collected through a 20ϫ objective (Zeiss Fluar, numerical aperture 0.75) and imaged using an Attofluor Imager device (Atto Instruments, Rockville, MD). Afterward, the same field of cells, loaded with 10 M PI for 10 min, at room temperature, were imaged for PI fluorescence. The dye was excited by light from a mercury lamp source, passed through a 555-nm excitation bandpass filter (10-nm bandwidth), reflected off of a mirror, and then passed through the 20ϫ objective. Emitted light was transmitted through a pinkel filter (Omega Optical), which allows 600-nm (20-nm bandwidth) wavelength light emitted from the dye to be collected to an Attofluor-intensified CCD camera. Images were visualized and overlaid using Attofluor RatioVision software (Atto Instruments, Brattleboro, VT).
The second method for measuring cell viability was a plate reader method. Cells plated into black 96-well plates (Packard Viewplates; Packard Instrument Co., Meriden, CT) were loaded with a final concentration of 3% Alamar blue dye (Biosource International, Camarillo, CA). Alamar blue is a dye that takes advantage of mitochondrial reductases to convert nonfluorescent resazurin to fluorescent resorufin ( excitation ϭ 535 nm, emission ϭ 580 nm). This dye has been used to measure neuronal viability successfully in primary neuronal culture (White et al., 1996) . Baseline fluorescence counts were read at room temperature in a Wallac plate reader within 1 min of the addition of Alamar blue (baseline), and again after a 1-h incubation at 37°C (signal). Fluorescence was expressed as a percentage of control untreated cells, after subtraction of background fluorescence. Live/dead cells were confirmed visually with a light microscope. Fura-2 Imaging. Cells were loaded with 5 M fura-2/AM for 1 h at 37°C. They were washed once with HBSS (Invitrogen) and assayed in HBSS buffer. Cells were placed onto the stage of a modified Attofluor Imager. High-speed, dual excitation of fura-2 was carried out using a RatioArc High-Speed Excitor, which rapidly switched excitation light between 334-and 380-nm wavelengths (10-nm bandwidth filters). Emitted light was transmitted through a 400-nm dichroic mirror, collected on an Attofluor-intensified CCD camera, and ratio-images were digitized, and analyzed, using Attofluor RatioVision software. Fluorescence intensity from each wavelength was analyzed from each sample by dividing the entire microscopic field into 99 regions of interest (ROI), which corresponded to approximately 200 to 400 cells. Background for each wavelength was defined by the fluorescence intensity of a region in the field with no cells, and was excluded using Attofluor RatioVision software algorithms. Some experiments were calibrated to absolute calcium values. To achieve this a standard two-point calibration method was performed using 50 M fura-2 pentasodium salt (Molecular Probes), a high-calcium buffer of 10 mM CaCl 2 , and a zero calcium buffer of 10 mM K 2 EGTA (Molecular Probes). Fluorescence intensity at 334 and 380 nm was measured for both the high-calcium buffer, and the zero calcium buffer, and values were applied to the standard radiometric dye
nM, R min ϭ ratio for zero calcium, R max ϭ ratio for high calcium, ␤ ϭ fluorescence of zero calcium at 380 nm/fluorescence of high calcium at 380 nm, and R ϭ ratio of the experimental 340 nm fluorescence/380 nm fluorescence (Grynkiewicz et al., 1985) .
Simultaneous SBFI and Fluo-4 Imaging. Cells were loaded with 5 M SBFI/AM (Molecular Probes) and 1 M fluo-4-AM (Molecular Probes) for 1 h at 37°C. They were washed once with HBSS and assayed in HBSS buffer. Cells were placed onto the stage of a modified Attofluor Imager. High-speed excitation of SBFI and fluo-4 was carried out using a RatioArc High-Speed Excitor, which rapidly switched excitation light among 334-, 380-, and 488-nm wavelengths (10-nm bandwidth filters, sampling rate was approximately one ratio image and one fluo-4 image per second). Emitted light was transmitted through a 490-nm longpass filter and collected to the Attofluorintensified CCD camera. SBFI ratio-images and fluo-4 single wavelength images were digitized, and analyzed, using Attofluor RatioVision software. No cross talk between any of the dyes was observed, because no signal above background was detected when SBFI-alone-loaded cells were excited with the fluo-4 excitation wavelength, or when fluo-4-alone-loaded cells were excited with either of the two SBFI excitation wavelengths. Analysis of the data from each wavelength was carried out as described above.
Imaging of Reactive Oxygen Species (ROS). Cells were loaded with the reactive oxygen species dye CM-H 2 DCFDA (5 M; Molecular Probes) for 1 h at 37°C. They were washed once with HBSS and assayed in HBSS buffer. Cells were placed onto the stage of a modified Attofluor Imager. Excitation of the dye was carried out at 488 nm (10-nm bandwidth filter). Emitted light was transmitted through a 490-nm longpass filter, collected on the Attofluor-intensified CCD camera, images were digitized, and analyzed, using Attofluor RatioVision software.
Statistical Analysis. Data comparisons of two groups were performed by Student's t test on GraphPad Prism software (GraphPad Software, San Diego, CA). Data comparisons of three or more groups were performed by one-way ANOVA followed by Tukey's post hoc analysis on GraphPad Prism software.
Results
Cloning of Human VR1 and Production of Stably Transfected hVR1 Cells. The human VR1 was cloned from a human thalamus cDNA library (Dubin et al., 2000) . HEK293 cells stably transfected with hVR1/pCDNA3.1(zeo) produced robust increases in intracellular Ca 2ϩ when challenged with 300 nM agonists capsaicin and RTX (Fig. 1A) . Pretreatment with 10 M antagonists ruthenium red and capsazepine completely blocked the agonist-induced response (Fig. 1B) 1C) .
VR1-Mediated Intracellular Calcium and Sodium Ion Concentration Changes in VR1-Expressing HEK293 Cells. VR1 stably transfected HEK293 cells were loaded with fura-2/AM to monitor intracellular calcium, or SBFI/AM to monitor intracellular sodium. Single-cell fluorescence imaging experiments, carried out on an Attofluor Imager device, revealed increases in both intracellular calcium and sodium concentrations in response to 3 M capsaicin (Fig. 2, A and B) . Conversion of the fura-2 ratio data to absolute calcium values revealed that the intracellular calcium concentration changed from a baseline of 48 Ϯ 11 to 753 Ϯ 26 nM in response to 3 M capsaicin (p Ͻ 0.001, n ϭ 4 -14 independent samples). Pretreatment with the VR1 receptor antagonist capsazepine (10 M) for 1 to 5 min completely blocked both the calcium and sodium response to capsaicin (Fig.  2, A and B) . Both capsaicin-induced Na ϩ and Ca 2ϩ responses were concentration-dependent. The capsaicin EC 50 values for both the calcium and sodium responses were closely matching, 81 versus 55 nM, respectively (Fig. 2, C and D) .
Intracellular levels of calcium and sodium ions were monitored simultaneously in the same population of cells after coloading fluo-4, a longer wavelength calcium indicator dye ( excitation ϭ 488 nm, emission ϭ 520 nm), with the ultraviolet range excitable sodium dye SBFI ( excitation ϭ 334 nm and 380 nm, emission ϭ 520 nm). Capsaicin (10 M) increased both intracellular calcium and sodium with a similar time course (Fig. 3, A and B) . Interestingly, when the antagonist capsazepine (50 M) or the vanilloid blocker ruthenium red (10 g/ml) was applied after agonist activation, intracellular calcium levels decreased, but intracellular sodium levels remained elevated (Fig. 3, A and B) . When cells were loaded with SBFI alone, and blockers were applied after agonist activation, the result was similar such that intracellular sodium levels remained elevated (data not shown), suggestive that this result is not due to nonspecific dye interactions. Therefore, it was possible to use these specific conditions to isolate the elevated sodium response to VR1 activation from the calcium response, and to more clearly delineate the role of sodium in VR1 toxicity in these cells. 3 . Characterization of hVR1 cell calcium and sodium responses upon antagonist addition after agonist activation. Intracellular calcium and sodium responses to 10 M capsaicin were imaged simultaneously in the same field of cells through concurrent monitoring of fluo-4, calcium indicator, and SBFI, sodium indicator. A, 50 M capsazepine was added 1.5 to 2 min after capsaicin. B, 10 g/ml ruthenium red was added 1.5 to 2 min after capsaicin. Data for each trace are the average of 99 ROI collected from a microscopic field of hVR1-HEK293 cells, representative of six to seven like experiments with similar results.
Pharmacological Characterization of VR1-Mediated
Toxicity in VR1-Expressing HEK293 Cells. Morphological assessment by using digital imaging at 20ϫ magnification revealed increased numbers of cells dead or dying after 12 to 15 h of continuous exposure to capsaicin (3 M) treatment compared with vehicle-treated control cells. Extensive cellular debris was evident, whereas control vehicle-treated cells appeared alive and healthy (Fig. 4A) . Overlay of PI fluorescence showed a significantly increased number of dead or dying cells in the capsaicintreated condition versus control or ruthenium red-protected cells (Fig. 4, A and B) . Concurrently, after 12 to 15 h of continuous capsaicin treatment, cells stained more extensively with the ROS dye CM-H 2 DCFDA, compared with Fig. 4 . Characterization of capsaicin toxicity in hVR1 cells. Cells were treated with vehicle control, 3 M capsaicin, or 3 M capsaicin plus 10 g/ml ruthenium red (RR) for 12 to 15 h in media at 37°C, 5% CO 2 . A, visible light digital images and fluorescence images of the dead cell dye PI ( excitation ϭ 555, emission ϭ 620) were collected from the same field of cells at the end of the treatment and overlaid. B, average Ϯ S.E.M. number of cells exhibiting PI fluorescence above background (n ϭ 3/condition). ‫,ءءء‬ p Ͻ 0.001 with respect to control and 10 g/ml RR, analyzed by one-way ANOVA followed by Tukey's post hoc analysis. C, cells were treated with vehicle control or 3 M capsaicin for 12 to 15 h in media at 37°C, 5% CO 2 then loaded with the ROS dye CM-H 2 DCFDA for 1 h, and dye fluorescence was imaged ( excitation ϭ 488, emission ϭ 520). Average Ϯ S.E.M. number of cells exhibiting CM-H 2 DCFDA fluorescence above background (n ϭ 3/condition). ‫,ء‬ p Ͻ 0.05 analyzed by Student's t test.
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VR1-mediated toxicity was assayed quantitatively on a plate reader by using Alamar blue, a well characterized fluorescent cell viability dye (White et al., 1996) . In live cells, nonfluorescent Alamar blue is converted by active mitochondrial reductases to the highly fluorescent derivative resorufin. Capsaicin-induced cell death was concentration-dependent (Fig. 5) , with an EC 50 of 96 Ϯ 20 nM (n ϭ 24), a value similar to that observed for capsaicin-induced calcium and sodium responses (Fig. 2, C and D) .
Pretreatment of the cells with capsazepine (10 M) or ruthenium red (2 or 6 g/ml) shifted the concentration-response curves to the right, and significantly increased the EC 50 of capsaicin by Ն2-fold at sufficient antagonist concentration (Fig. 5, A and B) . Addition of the antagonist capsazepine (10 M) 5 to 30 min after the onset of capsaicin treatment shifted the capsaicin toxicity curve to the right, and the EC 50 of capsaicin was increased under these conditions to the same extent as if the antagonist had been pretreated (Fig. 6 ). These data demonstrated that capsazepine was equally protective against capsaicin toxicity under conditions in which it could block both elevated intracellular calcium and sodium levels as under conditions in which it could only block the sustained calcium elevation selectively.
To further corroborate the observation that a selective block in the calcium response was preventive against VR1-mediated toxicity, simultaneous fluo-4 and SBFI imaging experiments were performed to determine conditions in which the intracellular calcium response could be selectively abolished by decreasing the extracellular calcium concentration. When extracellular calcium was reduced by 10-fold, down to 0.2 mM, full intracellular calcium and sodium responses to 10 M capsaicin were observed (Fig. 7, A and B) . Also, no protection against 10 M capsaicin toxicity was observed in 0.2 mM calcium extracellular buffer (Fig. 7D) . However, when the extracellular buffer contained 0.2 mM calcium and 1 mM EGTA, the intracellular calcium response was abolished, but the sodium response remained unchanged (Fig. 7C) . Correspondingly, in 0.2 mM calcium and 1 mM EGTA extracellular buffer, 10 M capsaicin exhibited no toxicity versus controls (Fig. 7D) .
pH Activation of VR1 Mediates a Transient Calcium Response but No Toxicity in VR1-Expressing HEK293 Cells. The VR1 channel can be activated by acidification as well as by pharmacological agonists (Tominaga et al., 1998) . Therefore, it was of interest to characterize the calcium response to lowered pH in the VR1 stable cell line and relate it to toxicity. Basal intracellular calcium was monitored in fura-2-loaded cells at pH 7.5. Upon addition of HCl, buffer pH rapidly dropped to 6.3, and the cells underwent a transient increase in intracellular calcium, which returned to basal levels with 2 min (Fig. 8A) . Pretreatment with the antagonist capsazepine completely blocked this transient calcium response to HCl, indicating that it was VR1-mediated (Fig. 8A) . However, the same low pH challenge did not mediate any toxicity compared with control cells monitored in pH 7.5 buffer (Fig. 8B) . Therefore, these data demonstrated that a VR1-mediated transient increase in intracellular calcium was not sufficient to trigger death of VR1-expressing HEK293 cells.
Discussion
The present study aimed to develop an experimental system to recapitulate capsaicin-induced cell death and to use that system, an HEK cell line stably expressing exogenously transfected VR1 receptor, to dissect the roles of different intracellular ionic changes in capsaicin toxicity. We demonstrated in this experimental system, using simultaneous ion imaging experiments as well as more classical methods such as alterations in extracellular buffer composition, that a sustained increase in intracellular calcium was the predominant ionic change inside the cell that lead to hVR1-mediated tox- Fig. 5 . Concentration-response of capsaicin toxicity in hVR1 cells. A, cells were treated with the indicated concentrations of capsaicin plus vehicle (f), or capsaicin after 10-min pretreatment with 10 M capsazepine (Ⅺ) in parallel for 12 to 15 h in media at 37°C, 5% CO 2 . Alamar blue fluorescence was measured and expressed as percentage of control as described under Experimental Procedures. The EC 50 for capsaicin plus vehicle is 125 nM (95% confidence interval, 105-149 nM). The EC 50 for capsaicin plus 10 M capsazepine pretreatment is 649 nM (95% confidence interval, 561-749 nM). Data are the average of eight experiments. B, cells were treated with the indicated concentrations of capsaicin plus vehicle (f), capsaicin after 10-min pretreatment with 2 g/ml ruthenium red (Ⅺ), or capsaicin after 10-min pretreatment with 6 g/ml ruthenium red (E) in parallel for 12 to 15 h in media at 37°C, 5% CO 2 . The EC 50 for capsaicin plus vehicle is 67 nM (95% confidence interval, 59 -76 nM). The EC 50 for capsaicin plus 2 g/ml ruthenium red pretreatment was 227 nM (95% confidence interval, 148 -348 nM). The EC 50 for capsaicin plus 6 g/ml ruthenium red pretreatment is Ͼ30 M. Data are the average of eight experiments. Fig. 6 . Effect of antagonist post-treatment on capsaicin toxicity in hVR1 cells. Cells were treated with the indicated concentrations of capsaicin plus vehicle (f), capsaicin followed by 10 M capsazepine 5 min later (‚), or capsaicin followed by 10 M capsazepine 30 min later (Ⅺ) in parallel for 12 to 15 h in media at 37°C, 5% CO 2 . The EC 50 for capsaicin plus vehicle is 125 nM (95% confidence interval, 105-149 nM). The EC 50 for capsaicin plus 10 M capsazepine at 5 min is 591 nM (95% confidence interval, 543-642 nM). The EC 50 for capsaicin plus 10 M capsazepine at 30 min is 482 nM (95% confidence interval, 398 -582 nM). Data are the average of eight experiments.
icity. In VR1-expressing HEK cells, neither VR1-mediated transient calcium increases nor sustained intracellular sodium changes contributed to VR1-mediated toxicity.
To date, both the rat and human orthologs of VR1 have been cloned (Caterina et al., 1997; Hayes et al., 2000) . Both have been extensively characterized for tissue expression, electrophysiological function, pharmacology, and calcium responsivity (Caterina et al., 1997; Cesare et al., 1999; Dubin et al., 2000; Hayes et al., 2000; Jerman et al., 2000) . The VR1 channel is expressed predominantly in small nociceptive neurons of the dorsal root ganglion (Tominaga et al., 1998) . It is a ligand-gated, nonselective cation channel that shows pronounced outward rectification (Caterina et al., 1997) . The receptor is activated by capsaicin (Szolcsanyi, 1996) and resiniferatoxin (Szolcsanyi et al., 1991) . Its activation is blocked by the antagonist capsazepine (Bevan et al., 1992) and vanilloid blocker ruthenium red (Wood et al., 1988) . Pharmacology of the rat VR1 receptor intracellular calcium response correlates well with what has been described in neurons Smart et al., 2000) .
When overexpressed in non-neuronal cells, prolonged activation of rat VR1 leads to cell death (Caterina et al., 1997) , a property that recapitulates capsaicin excitatory neurotoxicity in primary sensory neurons (Jancso et al., 1977 (Jancso et al., , 1985 ; 
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at ASPET Journals on July 12, 2017 jpet.aspetjournals.org Wood et al., 1988) . However, the VR1-mediated ionic signaling mechanisms that trigger cell death have not been determined. Because VR1 is functionally similar to other types of nonselective ligand-gated cation channels that also lead to cell death upon excessive activation, we reasoned that the ionic signaling trigger might also be comparable. In the ionotropic glutamate receptor system, it has been well established that calcium is a necessary trigger to initiate excitotoxicity in both neurons as well as in transfected nonneuronal cell lines (Choi, 1987; Munir et al., 1995; Grant et al., 1997) . Sustained intracellular calcium increases can result in the detrimental overactivation of downstream signaling enzymes such as protein kinases, phospholipases, and nitric-oxide synthase. Additionally, it may lead to a loss in the mitochondrial membrane potential that collectively may contribute to cell death (Choi, 1987; Munir et al., 1995; Grant et al., 1997) . However, increased intracellular sodium has also been implicated to play a significant role in ionotropic glutamate receptor-mediated cell death (Raymond et al., 1996; Itoh et al., 1998) . Therefore, the present study characterized VR1-mediated calcium and sodium signaling, and determined whether either or both of these intracellular ionic changes contribute to cell death. Very much like what has been reported for glutamate receptors, our studies have shown that an increase in intracellular calcium is necessary for induction of VR1-mediated toxicity in the stably transfected HEK293 cell model system. In addition to calcium, we characterized the VR1-mediated intracellular sodium response. Although an increase in intracellular sodium coincided with the calcium response to VR1 activation, the data do not suggest that sodium significantly contributes to VR1-mediated toxicity.
The data demonstrated that VR1 antagonist addition after agonist activation resulted in a diverging directional response of the intracellular calcium versus the intracellular sodium concentrations. Antagonists caused the calcium to return toward baseline, whereas the sodium remained elevated, or in some cases even slightly increased. Although the data in the present studies do not mechanistically explain these observations, some possibilities may be speculated. Antagonist binding after the channel already has been opened could result in an intermediate channel conformation, distinct from either the open conformation or the closed conformation, which may be more selectively permeable to monovalent cations. Evidence that a conformation with greater monovalent cation selectivity can occur has been reported where mutation of aspartate residue 646 on VR1 to an asparagine confers greater selectivity for sodium over divalent cations compared with wild type (Garcia-Martinez et al., 2000) . Alternatively, the effect may be due to the way the HEK293 cells handle the ionic load. The cells may pump out calcium more rapidly and efficiently than sodium. Therefore, once the ion source is blocked, the calcium ions may be cleared quickly, whereas sodium clearance may be relatively delayed.
The present studies demonstrated that the intracellular calcium response to protons was transient. This response was VR1-mediated because it was completely blocked in the presence of capsazepine. The response was not sufficient to confer VR1-mediated toxicity in these cells, suggesting that a sustained intracellular calcium response, like that which is elicited by capsaicin, is necessary. The hVR1 channel has been shown to mediate sustained whole-cell current responses to protons (Hayes et al., 2000) . However, reports of VR1-mediated intracellular calcium responses to protons are consistent with our data in that the calcium responses were transient . In fluorescence studies, the intracellular milieu is more similar to the viability studies in which the cells are intact than in whole-cell patch-clamp recordings where intracellular second messengers are lost. The discrepancy in time course of the response to protons when comparing a whole-cell current response and an intracellular calcium response might be explained by a number of possibilities. It is possible that the Ca 2ϩ -free solutions used in the electrophysiological studies modified the kinetics of the low pH response. Other possibilities may include a proton-dependent, selective desensitization of channel calcium permeability, or a proton-dependent activation of cellular clearance mechanisms for calcium.
A detailed understanding of hVR1 ionic signaling is crucial for discerning the downstream cellular consequences of activation of this important molecular target in peripheral pain processing pathways. Both agonists, as well as antagonists, of VR1 have been evaluated for analgesic efficacy in the clinic. Topical application of vanilloids, such as capsaicin (0.025% Zostrix and 0.075% Zostrix HP), have been used to mitigate neuropathic pain and treat the intractable pain associated with postherpetic neuralgia, diabetic neuropathy, postmastectomy pain, complex regional pain syndromes, and rheumatoid arthritis (Rowbotham, 1994 ; Szallasi and Blum- Robbins et al., 1998) . With prolonged exposure to capsaicin, nociceptor cells not only become insensitive to this agonist but also to other noxious stimuli (Szolcsanyi, 1993) . The mechanism by which capsaicin produces analgesia is not known but likely includes desensitization of nociceptive sensory neurons, depletion of peptides from peripheral terminals, as well as damage to sensory nerves (Jancso et al., 1977; Rowbotham, 1994) . The irritancy of capsaicin severely limits its use, and the discovery of novel compounds that block acidic and/or thermal activation of capsaicin-sensitive receptors is sought. However, the vanilloid blocker ruthenium red and the antagonist capsazepine, although exerting antinociceptive effects in a behavioral study (Santos and Calixto, 1997; Kress and Zeilhofer, 1999) , have not proven to be effective analgesics in humans (Kress and Zeilhofer, 1999) . Perhaps, the present studies, in conjunction with others, will advance a comprehensive understanding of the role of the VR1 channel in pain processing and neurodegeneration. Thereby, more effective treatments for pain, as well as for other nervous system disorders, may be more rationally discovered.
